Fundz

Blaze Bioscience reported raising $25 Million in an initial SEC Form D filing, from an offering of $25 Million

PRIVATEOct 21, 2024Late filing, first sale Oct 6, 2022

Amount Raised

$25 Million

$25 Million sold, per SEC Form D (first sale Oct 6, 2022)

Round Type

Venture

SeattleBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Blaze Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • Grid Therapeutics LLC raised $1.7M (Seed) on November 19, 2022.
  • Achieve Life Sciences raised $19M on November 18, 2022.
  • MedX Health raised an undisclosed amount (Convertible Note) on November 18, 2022.
  • Thiogenesis Therapeutics raised $218K on November 18, 2022.
  • PaxMedica raised an undisclosed amount on November 18, 2022.
  • SCA Health raised $18K (Pre-Seed) on November 18, 2022.

Who to call at Blaze Bioscience, and when

A new round usually means Blaze Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Blaze Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Blaze Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Blaze Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Blaze Bioscience

Location

530 FAIRVIEW AVENUE N.

Seattle, Washington, United States

About

Blaze Bioscience, Inc. is a privately held biotechnology company dedicated to improving the lives of cancer patients, starting with kids undergoing brain cancer surgery. By leveraging our Tumor Paint technology®, including the CANVAS Imaging system® and our CDP Discovery Platform, our goal is to make the detection, removal, and treatment of all cancers sensitive, reliable, and accessible, especially early-stage cancers where cure may still be possible.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Blaze Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts13 people are listed at Blaze Bioscience. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Blaze Bioscience's next move

See what Strategic adds

Blaze Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.